Wachtell-Led CVS Adds Glenview CEO, Others To Board

By Al Barbarino · November 18, 2024, 4:07 PM EST

CVS Health, represented by Wachtell Lipton Rosen & Katz, said Monday it has struck a deal with activist investor Glenview Capital Management to appoint four new board members, including Glenview CEO Larry...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Al

November 19, 2024
Kirkland Advises Amcor On $8.4B Berry Global Buy
November 12, 2024
DOJ Suing To Block UnitedHealth Unit's $3.3B Amedisys Deal
November 06, 2024
5 Firms Guide $4.6B Cencora-Retina Consultants Deal
October 30, 2024
Kirkland-Led Francisco Paying $1.1B For AdvancedMD
October 28, 2024
Crown Settles Customer Dispute To Close $924M Revance Buy
October 18, 2024
FTC Faces More Pressure To Block $16.5B Novo-Catalent Deal
October 10, 2024
Sen. Warren, Novo At Odds On Merits Of $16.5B Deal
August 20, 2024
J&J Boosting Cardio Portfolio With Up To $1.7B V-Wave Buy
August 13, 2024
3 Firms Drive $3.8B Carlyle-Baxter Kidney Care Deal
August 01, 2024
R1 RCM Going Private In $8.9B Deal Steered By 4 Firms